Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Evenity“
Suchtreffer
Begriffe & Kennungen
Evenity
Eintrag öffnenEvenity · 4.1 Therapeutic indications · 1
Eintrag öffnenEvenity · 4.3 Contraindications · 1
Eintrag öffnenEvenity · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.4)
Eintrag öffnenEvenity · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenEvenity · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenEvenity · 4.5 · No drug interaction studies have been performed with romosozumab. No pharmacokinetic drug interactions are exp
Eintrag öffnenEvenity · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenEvenity · 4.8 Undesirable effects · 1
Eintrag öffnenEvenity · 4.8 · 5 Frequency MedDRA System Organ Class Adverse reaction category Nasopharyngitis Very common Infections and inf
Eintrag öffnenEvenity · 4.8 · 6 Reporting of suspected adverse reactions
Eintrag öffnenEvenity · 4.8 · Description of selected adverse reactions
Eintrag öffnenEvenity · 4.8 · Immunogenicity Draft
Eintrag öffnenEvenity · 4.8 · In postmenopausal women dosed with monthly romosozumab, the incidence of anti-romosozumab antibodies was 18.6%
Eintrag öffnenEvenity · 4.8 · Myocardial infarction, stroke and mortality In the active-controlled trial of romosozumab for the treatment of
Eintrag öffnenEvenity · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEvenity · 4.8 · Summary of the safety profile
Eintrag öffnenEvenity · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenEvenity · 4.8 · The following convention has been used for the classification of the adverse reactions: very common (≥ 1/10),
Eintrag öffnenEvenity · 4.8 · The most common adverse reactions were nasopharyngitis (13.6%) and arthralgia (12.4%). Hypersensitivity-relate
Eintrag öffnen